课题基金 / 基金详情

ORAL ILOPROST ADMINISTERED FOR SEVERE PERIPHERAL ARTERIAL OCCLUSION

ORAL ILOPROST ADMINISTERED FOR SEVERE PERIPHERAL ARTERIAL OCCLUSION
口服伊洛前列素治疗严重外周动脉闭塞
批准号：
6113633
负责人：
FRED A WEAVER
金额：
$3.97万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/6113633
关键词：
artery occlusion cardiovascular disorder chemotherapy clinical research clinical trials dosage human subject human therapy evaluation iloprost longitudinal human study oral administration placebos

项目摘要

项目成果

FRED A WEAVER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a prospective double-blind, placebo-controlled, parallel-group, multi-national study of 600 patients with PAOD III and IV who will be randomly assigned to one of the following treatments for 6 months t oral iloprost 50 mcg bid, or oral iloprost 100-150 mcg bid, or matching placebo bid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
IV LIPO PGE THERAPY IN PATIENTS WITH ISCHEMIC ULCERS